These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Interaction of thyroid-stimulating antibody with Graves' thyroid-stimulating hormone-binding antibody. Ochi Y; Kajita Y; Hamazu M; Nagata A Horm Res; 2003; 59(5):222-8. PubMed ID: 12714785 [TBL] [Abstract][Full Text] [Related]
7. Persistent Graves' hyperthyroidism despite rapid negative conversion of thyroid-stimulating hormone-binding inhibitory immunoglobulin assay results: a case report. Ohara N; Kaneko M; Kitazawa M; Uemura Y; Minagawa S; Miyakoshi M; Kaneko K; Kamoi K J Med Case Rep; 2017 Feb; 11(1):32. PubMed ID: 28162094 [TBL] [Abstract][Full Text] [Related]
8. Comparison of new different assay systems for thyrotropin receptor antibodies with reference to thyroid-stimulating antibodies and thyroid stimulation-blocking antibodies in Graves' disease. Hirooka Y; Li C; Takagi J; Gotoh M; Habu S; Yasaka-Nomura T; Ishihara R; Nakasone Y; Nakamura R; Morikawa R; Otake K; Nogimori T; Ishizuki Y Int J Clin Pharmacol Res; 2004; 24(4):111-6. PubMed ID: 15754915 [TBL] [Abstract][Full Text] [Related]
9. The relationship of thyrotropin receptor antibody levels to the severity of thyroid orbitopathy. Shokeir MO; Pudek MR; Katz S; Rootman J; Kendler DL Clin Biochem; 1996 Apr; 29(2):187-9. PubMed ID: 8601331 [No Abstract] [Full Text] [Related]
10. Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy. Kung AW; Lau KS; Kohn LD J Clin Endocrinol Metab; 2001 Aug; 86(8):3647-53. PubMed ID: 11502791 [TBL] [Abstract][Full Text] [Related]
11. Comparison of a solid phase human- versus porcine- thyrotropin receptor-based immunoassay for the measurement of thyrotropin receptor antibodies in patients with thyroid diseases. Hermsen D; Liu C; Domberg J; Graeber C; Feldkamp J; Duan Y; Xu K; Liu C; Mao X; Scherbaum WA; Schott M Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S59-63. PubMed ID: 18777457 [TBL] [Abstract][Full Text] [Related]
12. [Graves disease in pregnancy a risk for the child. Maternal TSH receptor antibodies can cause fetal and neonatal thyrotoxicosis]. Roos M; Sjöberg O; Axelsson O; Karlsson FA Lakartidningen; 2008 Jan 16-22; 105(3):120-4. PubMed ID: 18290505 [No Abstract] [Full Text] [Related]
13. Direct binding of thyrotropin receptor autoantibody to in vitro translated thyrotropin receptor: a comparison to radioreceptor assay and thyroid stimulating bioassay. Morgenthaler NG; Hodak K; Seissler J; Steinbrenner H; Pampel I; Gupta M; McGregor AM; Scherbaum WA; Banga JP Thyroid; 1999 May; 9(5):466-75. PubMed ID: 10365678 [TBL] [Abstract][Full Text] [Related]
14. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease. Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477 [TBL] [Abstract][Full Text] [Related]
15. Relationship between thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins years after administration of radioiodine for Graves' disease: retrospective clinical survey. Yoshida K; Aizawa Y; Kaise N; Fukazawa H; Kiso Y; Sayama N; Mori K; Hori H; Abe K J Endocrinol Invest; 1996 Nov; 19(10):682-6. PubMed ID: 9007700 [TBL] [Abstract][Full Text] [Related]
16. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease]. González-González A; Recio Cordova JM; Aznar Ondoño I; Del Monte Jarabo Bueno M Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750 [TBL] [Abstract][Full Text] [Related]
17. The negative correlation between thyrotropin receptor-stimulating antibodies and bone mineral density in postmenopausal patients with Graves' disease. Amashukeli M; Korinteli M; Zerekidze T; Jikurauli N; Shanava S; Tsagareli M; Giorgadze E J Investig Med; 2013 Jun; 61(5):842-7. PubMed ID: 23612147 [TBL] [Abstract][Full Text] [Related]
18. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
19. The Presence of Thyroid-Stimulation Blocking Antibody Prevents High Bone Turnover in Untreated Premenopausal Patients with Graves' Disease. Cho SW; Bae JH; Noh GW; Kim YA; Moon MK; Park KU; Song J; Yi KH; Park do J; Chung JK; Cho BY; Park YJ PLoS One; 2015; 10(12):e0144599. PubMed ID: 26650844 [TBL] [Abstract][Full Text] [Related]
20. [The latest progress in the pathogenesis and diagnosis of Graves' disease]. Kimura T; Okamoto Y Nihon Rinsho; 2012 Nov; 70(11):1908-12. PubMed ID: 23214060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]